InvestorsHub Logo
Followers 3821
Posts 238471
Boards Moderated 0
Alias Born 07/30/2007

Re: crudeoil24 post# 322

Friday, 10/13/2017 12:17:52 AM

Friday, October 13, 2017 12:17:52 AM

Post# of 504
What date was this from? Remember we were at a dollar recently.

Analyst Jim Birchenough is bullish on the company following selection of IPI-549 monotherapy data as a late breaker oral presentation at SITC annual meeting next month. The analyst comments "Based on prior SITC late breaker data we see a reasonable likelihood of proof-of-concept response rate data, and with likely validation of tumor macrophage targeting in immunooncology (IO) and a unique mechanism of action we see upside potential not reflected at current stock price."